28th International Workshop on Kaposi’s Sarcoma Herpesvirus & Related Agents

28 June – 1 July, 2026

CSSB Centre for Structural Systems Biology, Hamburg, Germany

KSHV 2026 will assemble an interdisciplinary group of scientists to discuss a cancer-causing herpesvirus, driving a variety of malignancies and lymphoproliferative disorders, including Kaposi’s sarcoma, pleural effusion lymphoma, multicentric Castleman’s disease, and KSHV-inflammatory cytokine syndrome (KICS). Frequently found in patients with HIV-AIDS and other forms of immunosuppression, including treatments for organ transplant, malaria, and autoimmune diseases, most of these virus-associated malignancies are likely to involve complex genetic predispositions and/or high-risk environmental co-factors. New and better therapies are needed for treating and preventing these virus-associated malignancies.

The major focus of the KSHV meeting is the biology of oncogenic herpesviruses and associated human diseases, with specific emphasis on viral pathogenesis, viral latency and reactivation, viral gene expression and replication, host responses to infection, epidemiology, vaccine development, therapeutic intervention, clinical and translational research.

In addition to KSHV, studies related to herpesvirus saimiri (HVS), murine herpesvirus-68 (MHV-68), and rhesus rhadinovirus (RRV) will be presented. The 28th International Workshop on Kaposi’s Sarcoma-Associated Herpesvirus and Related Agents will build on research conducted on KSHV since the discovery of this virus in 1994, to engage clinicians and researchers in diverse populations and geographies.

Investigators of all career levels are encouraged to submit abstracts for oral or poster presentation by the 16th of March, Abstract Submission Deadline. Several Travel Awards will be available to qualifying trainees (graduate students, postdocs and pre-doctoral study technicians working in academic or government labs), application is through the online Abstract Submission form.